SOLENO THERAPEUTICS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Soleno Therapeutics Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2024.
  • Soleno Therapeutics Inc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $2.99M, a 531% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.99M +$2.52M +531% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $268K -$273K -50.5% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $338K +$285K +538% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $407K +$276K +211% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $474K +$268K +130% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $541K +$262K +93.9% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $53K -$297K -84.9% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $131K -$290K -68.9% Dec 31, 2022 10-K 2024-03-07
Q3 2022 $206K -$283K -57.9% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $279K -$321K -53.5% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $350K +$300K +600% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $421K +$297K +240% Dec 31, 2021 10-K 2023-03-22
Q3 2021 $489K +$294K +151% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $600K +$335K +126% Jun 30, 2021 10-Q 2023-05-09
Q1 2021 $50K -$282K -84.9% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $124K -$274K -68.8% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $195K Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $265K Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $332K Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $398K Dec 31, 2019 10-K 2021-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.